logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sacha I. Rothschild

universita della svizzera italiana
H指数:41
被引数:9,820

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease

脑膜癌病鞘内治疗中的决策制定

Oncology
IF1.8
2026-05-010
PRE
Weindler, Susanne; Hundsberger, Thomas; Addeo, Alfredo; Froesch, Patrizia; Fruh, Martin; Gautschi, Oliver; Hasler-Strub, Ursula; Janthur, Wolf-Dieter; Mangana, Joanna; Mangas, Cristina; Mark, Michael Thomas; Maul, Julia-Tatjana; Maul, Lara Valeska; Mauti, Laetitia Arja; Metaxas, Yannis; Nothhelfer, Tilly; Ozdemir, Berna C.; Le Rhun, Emilie; Rothschild, Sacha I.; Schmid, Sabine; Seystahl, Katharina; Schucht, Philippe; Vetter, Marcus; Weller, Michael; Witzel, Isabell; Zaman, Khalil; Putora, Paul Martin; Glatzer, Markus
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14

性别特异性的疗效和安全性结局：在接受新辅助治疗的可切除III期非小细胞肺癌（NSCLC）患者中的联合分析——SAKK试验16/96、16/00、16/01、16/08和16/14

ESMO Open
IF8.3
2025-11-100
OAAI
L. Frehner; S. Schär; S. Hayoz; M. Guckenberger; T. Finazzi; M. Mark; A. Addeo; L.A. Mauti; D. Betticher; R. Stupp; A. Curioni-Fontecedro; S. Peters; M. Früh; S.I. Rothschild; M. Pless; D. König; I. Opitz; H.B. Ris; B.C. Özdemir; S. Schmid
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastases

一线免疫治疗±化疗，联合或不含 upfront 立体定向放射治疗（SRT）在无症状脑转移的非小细胞肺癌（NSCLC）患者中的应用

Lung Cancer
IF4.4
2025-11-030
PRE
Lorenz Frehner; Sämi Schär; Stefanie Hayoz; Verena Petermichl; Philip Speicher; Sacha I. Rothschild; Laetitia A. Mauti; David König; Tobias Finazzi; Patrizia Froesch; Sabrina Marini; Anna Allemann; Michael Mark; Wolf-Dieter Janthur; Antonia Stamatiou; Yannis Metaxas; Ekin Ermis; Franca Wagner; Martin Früh; Sabine Schmid
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy
Nature Communications
IF15.7
2025-09-300
OAAI
Dominic Schmid; Bettina Sobottka; Massimiliano Manzo; Marta Trüb; Katharina Leonards; Petra Herzig; Oluwaseun Rume-Abiola Oyewole; Philip Jermann; Stefanie Hayoz; Spasenija Savic Prince; Giulia Tochtermann; Marina Natoli; Miklos Pless; Adrienne Bettini; Martin Früh; Laetitia A. Mauti; Christian Britschgi; Solange Peters; Michael Mark; Adrian F. Ochsenbein; Wolf-Dieter Janthur; Christine Waibel; Nicolas Mach; Patrizia Froesch; Martin Buess; Pierre Bohanes; Michel Gonzalez; Ilaria Alborelli; Sacha I. Rothschild; Viktor Hendrik Koelzer; Alfred Zippelius
Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland

法国、英国和瑞士接受KRAS突变检测的晚期非小细胞肺癌患者的临床特征、医疗资源使用及生存结局。

Journal of Medical Economics
IF3
2025-08-080
OA
Marie Wislez; Andromachi Giannopoulou; Isabelle Borget; Colin Lindsay; Sacha I. Rothschild; Bastien Vincent; Joseph Milce; Ihtisham Sultan; Björn Stollenwerk; Miklos Pless
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

SCLC的一线化学免疫疗法: 一项两国现实世界研究的结果

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-01-010
OA
Moliner, Laura; Zellweger, Nuria; Schmid, Sabine; Bertschinger, Martina; Waibel, Christine; Cerciello, Ferdinando; Froesch, Patrizia; Mark, Michael; Bettini, Adrienne; Blum, Veronika; Holer, Lisa; Hayoz, Stefanie; Fruh, Martin; Ahmed, Samreen; Haeuptle, Pirmin; Bhagani, Shradha; Steele, Nicola; Gray, Hannah-Leigh; Robinson, Stephen D.; Davidson, Michael; Cox, Samantha; Khalid, Taha; Geldart, Tom R.; Nolan, Luke; Scott, Deborah C.; Hennah, Lindsay; Newsom-Davis, Tom; Rathbone, Emma; Handforth, Catherine; Denton, Arshi; Merchant, Shairoz; Blackhall, Fiona; Mauti, Laetitia A.; Califano, Raffaele; Rothschild, Sacha I.
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment

接受Ipilimumab和Nivolumab联合作为一线或后续治疗的恶性胸膜间皮瘤患者的真实结果

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-12-010
OA
Schmid, Sabine; Holer, Lisa; Gysel, Katrin; Koster, Kira-Lee; Rothschild, Sacha I.; Boos, Laura A.; Frehner, Lorenz; Almeida, Sabine Cardoso; Britschgi, Christian; Metaxas, Yannis; Mark, Michael; Froesch, Patrizia; Janthur, Wolf-Dieter; Allemann, Anna; Waibel, Christine; von der Muhll-schill, Catherine; Fruh, Martin; Mauti, Laetitia A.
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology

报告临床癌症护理中的体细胞变异: 瑞士分子病理学会的建议

VIRCHOWS ARCHIV
IF3.1
2024-10-230
OAAI
Christinat, Yann; Hamelin, Baptiste; Alborelli, Ilaria; Angelino, Paolo; Barbie, Valerie; Bisig, Bettina; Dawson, Heather; Frattini, Milo; Grob, Tobias; Jochum, Wolfram; Nienhold, Ronny; Mckee, Thomas; Matter, Matthias; Missiaglia, Edoardo; Molinari, Francesca; Rothschild, Sacha; Sobottka-Brillout, Anna Bettina; Vassella, Erik; Zoche, Martin; Mertz, Kirsten D.
Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine
BJU INTERNATIONAL
IF4.4
2024-03-083
PRE
Afferi, Luca; Spahn, Martin; Hayoz, Stefanie; Strebel, Rato T.; Rothschild, Sacha I.; Seifert, Helge; Ozdemir, Berna C.; Kiss, Bernhard; Maletzki, Philipp; Engeler, Daniel; Wirth, Gregory; Hadaschik, Boris; Lucca, Ilaria; John, Hubert; Sauer, Andreas; Muntener, Michael; Bubendorf, Lukas; Schneider, Martina; Musilova, Jana; Petrausch, Ulf; Cathomas, Richard
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-03-010
OA
Mark, Michael; Froesch, Patrizia; Gysel, Katrin; Rothschild, Sacha I.; Addeo, Alfredo; Ackermann, Christoph J.; Chiquet, Sabrina; Schneider, Martina; Ribi, Karin; Maranta, Angela Fischer; Bastian, Sara; von Moos, Roger; Joerger, Markus; Frueh, Martin
Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR plus NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Saalfeld, F. C.; Moeller, J.; Michels, S.; Grohe, C.; Wiesweg, M.; Schubart, C.; Alt, J.; Griesinger, F.; Kauffmann-Guerrero, D.; Kulhavy, J.; Overbeck, T. R.; Pelusi, N.; Rohde, G.; Wesseler, C.; Vathiotis, I.; Veluswamy, R.; Illini, O. M.; Rothschild, S. I.; Christopoulos, P.; Wermke, M.
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study

肿瘤标志物在复发检测中的价值-瑞士奥地利德国睾丸癌队列研究的经验教训

EUROPEAN UROLOGY OPEN SCIENCE
IF4.5
2023-04-0111
OAAI
Fischer, Stefanie; Rothermundt, Christian; Stalder, Odile; Terbuch, Angelika; Hermanns, Thomas; Zihler, Deborah; Mueller, Beat; Fankhauser, Christian D.; Hirschi-Blickenstorfer, Anita; Seifert, Bettina; Kluth, Luis Alex; Ufe, Mark -Peter; Mingrone, Walter; Templeton, Arnoud J.; Fischer, Natalie; Rothschild, Sacha; Woelky, Regina; Gillessen, Silke; Cathomas, Richard

研究方向

暂未获取到该数据
A
Alfred Zippelius
H 指数:74论文数:552被引数:2.6万
O
Oliver Gautschi
H 指数:60论文数:479被引数:1.7万
M
Martin Früh
H 指数:39论文数:209被引数:1.1万
M
Miklos Pless
H 指数:44论文数:255被引数:9,661
S
Stefanie Hayoz
H 指数:28论文数:214被引数:3,456
L
Laetitia Mauti
H 指数:8论文数:50被引数:628
M
Michael Mark
H 指数:17论文数:131被引数:1,167
P
Patrizia Froesch
H 指数:17论文数:71被引数:1,534
S
Sabine Schmid
H 指数:25论文数:125被引数:3,422
S
Solange Peters
H 指数:112论文数:941被引数:7.0万